Partnership Contribution Implementation
The PIP Framework established a Benefit Sharing System that includes an annual Partnership Contribution (PC) to WHO from influenza vaccine, diagnostic and pharmaceutical manufacturers using the WHO Global Influenza Surveillance and Response System (GISRS). The amount of the annual contribution is equivalent to 50% of the running costs of the GISRS . These contributions have been collected annually since 2012. The distribution of these funds between industry partners is based on transparency, equity and the nature and capacity of their businesses in the influenza product market. The contributions are used to strengthen pandemic preparedness and response capacities, mostly in developing countries where they are weak.
The majority of preparedness activities are under the responsibility of the WHO Regional Offices that work through Country Offices to strengthen capacities where they are most needed at the field level.
Partnership Contribution Implementation Plan II
Partnership Contribution Implementation Plan, 2013-2016
Partnership Contribution Implementation Plan, 2013-2016, updated January 2015
Partnership Contribution Implementation Plan, 2013-2016, January 2014
Partnership Contribution Gap Analyses
- Critical Path Analysis: From Detection to Protection
Partnership Contribution Implementation Annual Reports
Distribution of funds
Director-General's Report to EB131
PIP Advisory Group recommendations to the Director-General on potential use of Partnership Contribution, 16 May 2012